Condition
Arrhythmogenic Right Ventricular Dysplasia clinical trials and research
As of November 12, 2026, Find a Trial lists 6 Arrhythmogenic Right Ventricular Dysplasia clinical trials that are recruiting, at sites in 5 countries (most in France (2), United Kingdom (2), Germany (1)). By phase: Phase 2 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 6Clinical trials
- 5Countries
Newest Arrhythmogenic Right Ventricular Dysplasia clinical trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| Registry for hereditary cardiovascular diseases in Brazil | — | Rio Branco, Acre and 26 other locations | Recruiting | Aug 9, 2024 |
| Long-term outcomes for patients with cardiac arrhythmias | — | Hamburg | Recruiting | Aug 30, 2022 |
| Investigating Inflammation in Arrhythmogenic Right Ventricular Cardiomyopathy | — | Toulouse | Recruiting | Jan 27, 2022 |
| Using cheek (buccal) cells to detect cell-junction protein changes in inherited arrhythmias | — | London | Recruiting | Feb 6, 2020 |
| Blocking a hormone system to treat heart issues in ARVD patients | Phase 2 | Amiens and 12 other locations | Recruiting | Jul 20, 2018 |
| Registry and biobank for arrhythmogenic ventricular cardiomyopathy | — | Rochester, Minnesota and 1 other locations | Recruiting | Feb 10, 2017 |
All recruiting trials (6)
-
Registry for hereditary cardiovascular diseases in Brazil
This study is trying to create a registry of Brazilian patients with hereditary heart diseases to see how common certain genetic changes are in people with these conditions.
-
Long-term outcomes for patients with cardiac arrhythmias
This study looks at how well treatments for heart rhythm problems work over time and what factors might affect their success for patients with conditions like atrial fibrillation and ventricular tachycardia.
-
Investigating Inflammation in Arrhythmogenic Right Ventricular Cardiomyopathy
This study is trying to see if inflammation in the heart plays a role in arrhythmogenic right ventricular cardiomyopathy and how it might help us understand the disease better.
-
Using cheek (buccal) cells to detect cell-junction protein changes in inherited arrhythmias
This project will test whether a painless cheek-swab can reveal the same heart cell-junction protein changes in people with inherited arrhythmias such as arrhythmogenic cardiomyopathy, Brugada syndrome, and other channelopathies.
-
Blocking a hormone system to treat heart issues in ARVD patients
This study is testing if the medication spironolactone can help people with Arrhythmogenic Right Ventricular Dysplasia (ARVD) by slowing down heart problems and reducing irregular heartbeats.
-
Registry and biobank for arrhythmogenic ventricular cardiomyopathy
This study is trying to gather information and samples from people with arrhythmogenic ventricular cardiomyopathy and their families to better understand the genetic causes of the condition and improve early diagnosis for those at risk.
Related topics
Quick answers
How many Arrhythmogenic Right Ventricular Dysplasia clinical trials are recruiting right now?
6, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 5 countries. The most sites are in France (2 trials), United Kingdom (2 trials), Germany (1 trial), United States (1 trial), Brazil (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 2: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.